Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0480
+0.0080 (20.00%)
Jun 29, 2026, 9:35 AM EST
Oncotelic Therapeutics Employees
As of December 31, 2025, Oncotelic Therapeutics had 43 total employees, including 38 full-time and 5 part-time employees. The number of employees increased by 13 or 43.33% compared to the previous year.
Employees
43
Change (1Y)
13
Growth (1Y)
43.33%
Revenue / Employee
n/a
Profits / Employee
$6,033,775
Market Cap
19.78M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ZIVO Bioscience | 7 |
| Anebulo Pharmaceuticals | 3 |
| Inhibitor Therapeutics | 8 |
| Galera Therapeutics | 3 |
| Provectus Biopharmaceuticals | 6 |
| Zeo ScientifiX | 20 |
Oncotelic Therapeutics News
- 11 days ago - Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026 - GlobeNewsWire
- 12 days ago - Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services - GlobeNewsWire
- 24 days ago - NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Exploration of Nanoparticle, Targeted Drug-Delivery Technologies - GlobeNewsWire
- 25 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies - GlobeNewsWire
- 26 days ago - Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program - GlobeNewsWire
- 27 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure - GlobeNewsWire
- 4 weeks ago - TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics - GlobeNewsWire
- 6 weeks ago - Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress - GlobeNewsWire